NantHealth (NYSE:NH) vs. Allscripts Healthcare Solutions (MDRX) Head-To-Head Contrast

Allscripts Healthcare Solutions (NASDAQ: MDRX) and NantHealth (NYSE:NH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitabiliy.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Allscripts Healthcare Solutions and NantHealth, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allscripts Healthcare Solutions 1 8 8 0 2.41
NantHealth 0 0 4 0 3.00

Allscripts Healthcare Solutions presently has a consensus target price of $14.50, suggesting a potential upside of 9.43%. NantHealth has a consensus target price of $10.38, suggesting a potential upside of 142.41%. Given NantHealth’s stronger consensus rating and higher probable upside, analysts plainly believe NantHealth is more favorable than Allscripts Healthcare Solutions.

Earnings and Valuation

This table compares Allscripts Healthcare Solutions and NantHealth’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Allscripts Healthcare Solutions $1.62 billion 1.48 $153.38 million ($1.06) -12.50
NantHealth $103.44 million 5.03 -$147.00 million N/A N/A

Allscripts Healthcare Solutions has higher revenue and earnings than NantHealth.

Profitability

This table compares Allscripts Healthcare Solutions and NantHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Allscripts Healthcare Solutions -11.54% 5.97% 1.96%
NantHealth -182.66% -42.22% -24.91%

Summary

Allscripts Healthcare Solutions beats NantHealth on 6 of the 9 factors compared between the two stocks.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc. (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions. The Population Health segment includes the sale of health management and coordinated care solutions, which focus on hospitals, health systems, other care facilities and accountable care organizations (ACOs). The Netsmart segment provides software and technology solutions to the health and human services industry, which includes behavioral health, addiction treatment, intellectual and developmental disability services, child and family services and public health segments, as well as to post-acute home care organizations.

About NantHealth

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply